Works Cited

1. Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are Common Treatments for Cerebral Palsy? Available at https://www.nichd.nih.gov/health/topics/cerebral-palsy/conditioninfo/treatments. Last accessed October 25, 2021.

2. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 8th ed. St. Louis, MO: Mosby; 2018.

3. Copstead LE. Pathophysiology. 6th ed. St. Louis, MO: Mosby; 2018.

4. Mitchell RN, Robbins SL. Pocket Companion to Robbins and Coltran Pathologic Basis of Disease. 8th ed. Philadelphia, PA: Saunders; 2012.

5. Rowland MD. Merritt's Neurology. 11th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2005.

6. Rae-Grant A. Weiner and Levitt's Neurology. 8th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.

7. Nowak T. Pathophysiology: Concepts and Applications for Health Care Professionals. 3rd ed. Boston, MA: McGraw-Hill; 2011.

8. Biller J. Practical Neurology. 5th ed. Philadelphia, PA: Wolters Kluwer; 2017.

9. Galvagno SM. Emergency Pathophysiology: Clinical Applications for Prehospital Care. Jackson, WY: Teton NewMedia; 2013.

10. Hall J. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016.

11. Campbell WW, Dejong RN. DeJong's The Neurologic Examination. 7th ed. Philadelphia, PA: Wolters Klower; 2012.

12. Ellenbogen RG, Sekhar LN, Kitchen D. Principles of Neurological Surgery. 4th ed. Philadelphia, PA: Elsevier; 2018.

13. Berg SM, Bittner EA. Massachusetts General Hospital Review of Critical Care Medicine. Philadephia, PA: Wolters Kluwer, Lippincott, Williams & Wilkins; 2014.

14. Hankey G, Wardlaw JM. Clinical Neurology. New York, NY: Demos Medical; 2008.

15. Singh A. Case-Based Neurology. New York, NY: Demos Medical; 2012.

16. Futrell N, Jamieson DG. Vascular Neurology. New York, NY: Demos Medical; 2008.

17. Gulanick. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 9th ed. St. Louis, MO: Elsevier Health Sciences; 2017.

18. Haberland C. Clinical Neuropathology. New York, NY: Demos Medical; 2007.

19. Araim RJ, Aghlar MR. Neuromuscular Quick Pocket Reference. New York, NY: Demos Medical; 2012.

20. Howard J. Neurology Video Textbook. New York, NY: Demos Medical; 2013.

21. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;(2):CD006866.

22. DiPiro J. Pharmacotherapy A Pathophysiologic Approach. 10th ed. New York, NY: McGraw-Hill; 2017.

23. Zane RD, Kosowsky JM. Pocket Emergency Medicine. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2015.

24. Markovchick VJ, Pons PT, Bakes KM, Buchanan JA. Emergency Medicine Secrets. 6th ed. Philadelphia, PA: Elsevier; 2016.

25. Grossman SC, Porth CM. Pathophysiology: Concepts of Altered Health States. Philadephia, PA: Lippincott, Williams and Wilkins; 2014.

26. Bruyere HJ Jr. 100 Case Studies in Pathophysiology. Philadelphia, PA: Lippincott, Williams and Wilkins; 2009.

27. Bope ET, Kellerman RD, Conn HF. Conn's Current Therapy 2016. Philadelphia, PA: Elsevier; 2016.

28. Marshall RS, Mayer SA. On Call Neurology. 3rd ed. Philadelphia, PA: Elsevier; 2007.

29. Nelms M. Nutrition Therapy and Pathophysiology. 3rd ed. Boston, MA: Cengage Learning; 2016.

30. Ackley BJ, Ladwig GB, Flynn Makic MB. Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 11th ed. St. Louis, MO: Elsevier; 2017.

31. Zerwekh JA, Claborn JC. Mosby's Pharmacology Memory Notecards. 4th ed. St. Louis, MO: Elsevier; 2015.

32. Buttaro T, Trybulski J, Polgar-Bailey P, Sandberg-Cook J. Primary Care: A Collaborative Practice. 5th ed. St. Louis, MO: Elsevier; 2017.

33. Hickey JV. The Clinical Practice of Neurological and Neurosurgical Nursing. 7th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2014.

34. Domino FJ. The 5-Minute Clinical Consult Standard 2016. 24th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2015.

35. Ford SM, Roach SS. Roach's Introductory Clinical Pharmacology. 10th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2014.

36. Caplan L. Caplan's Stroke: A Clinical Approach. 5th ed. Cambridge: Cambridge University Press; 2016.

37. Ferrell BR, Paice JA. Oxford Textbook of Palliative Nursing. 5th ed. New York, NY: Oxford University Press; 2019.

38. Ehrman J, Gordon PM, Visich PS, Keteyian SJ. Clinical Exercise Physiology. 3rd ed. Champaign, IL: Human Kinetics Publishing; 2013.

39. Baird MS. Manual of Critical Care Nursing: Nursing Interventions and Collaborative Management. 7th ed. St. Louis, MO: Mosby; 2016.

40. Ladwig GE, Ackley B, Flynn Makic MB. Mosby's Guide to Nursing Diagnosis. 5th ed. St. Louis, MO: Elsevier; 2016.

41. Barkauskas VH, Baumann LC, Darling-Fisher CS. Health and Physical Assessment. 3rd ed. St. Louis, MO: Mosby; 2002.

42. Black JM, Hawks JH, Luckmann J. Medical Surgical Nursing: Clinical Management for Positive Outcomes. 8th ed. Philadelphia, PA: W.B. Saunders; 2009.

43. Brashers VL. Clinical Applications of Pathophysiology: Assessment, Diagnostic Reasoning and Management. 2nd ed. St. Louis, MO: Mosby; 2002.

44. Hall JE, Guyton A. Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016.

45. Huether SE, McCance KL. Understanding Pathophysiology. 6th ed. St. Louis, MO: Mosby; 2017.

46. LeMone P. Medical Surgical Nursing: Critical Thinking in Client Care. 5th ed. Boston, MA: Pearson; 2014.

47. Bullock BA. Focus on Pathophysiology. Philadelphia, PA: Lippincott; 2000.

48. Corwin EJ. Handbook of Pathophysiology. 3rd ed. Philadelphia, PA: Wolters Kluwer; 2015.

49. Price SA. Pathophysiology: Clinical Concepts of Disease Processes. 6th ed. St. Louis, MO: Mosby; 2003.

50. Patten JP. Neurological Differential Diagnosis. 2nd ed. New York, NY: Springer; 2000.

51. Johnson MV. Principles of Drug Therapy in Neurology. 2nd ed. New York, NY: Oxford University Press; 2008.

52. Wilson BA, Shannon MT, Shields KM. Pearson Nurse's Drug Guide for 2017. Boston, MA: Pearson Publishing; 2017.

53. Plum F, Posner JB. Diagnosis of Stupor and Coma. 3rd ed. New York, NY: Oxford University Press; 2000.

54. Wilson BA, Shannon MT, Shields KM. Pearson Nurse's Drug Guide 2011. New York, NY: Pearrson; 2011.

55. Alberstone CD, Steinmetz MP. Anatomic Basis of Neurologic Diagnosis. 2nd ed. New York, NY: Thieme Publishing; 2011.

56. Rubin D, Daube JR. Clinical Neurophysiology. 4th ed. Oxford, Oxford University Press; 2016.

57. Bedlack RS, Mitsumoto H. Amyotrophic Lateral Sclerosis: A Patient Care Guide for Clinicians. New York, NY: Demos Medical; 2013.

58. Harvey R, Stein J. Stroke Recovery and Rehabilitation. 2nd ed. New York, NY: Demos Medical; 2014.

59. Cristian A. Medical Management of Adults with Neurologic Disabilities. New York, NY: Demos Medical; 2009.

60. Cifu DX, Caruso D. Traumatic Brain Injury. New York, NY: Demos Medical; 2010.

61. Prahlow N, Kincaid JC, Buschbacher RM. Neuromuscular Rehabilitation. New York, NY: Demos Medical; 2014.

62. Zasler ND, Katz DI. Brain Injury Medicine: Principles and Practice. 2nd ed. New York, NY: Demos Medical; 2013.

63. MedlinePlus. Interferon Beta-1b Injection. Available at https://medlineplus.gov/druginfo/meds/a601151.html. Last accessed October 25, 2021.

64. Perret D, Chang EY, Hata J, Chen H, Tribuzio B. The Pain Center Manual. New York, NY: Demos Medical; 2014.

65. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676-685.

66. Mulley JC, Scheffer IE, Harkin LA, Berkovic SF, Dibbens LM. Susceptibility genes for complex epilepsy. Hum Mol Genetics. 2005;14(R2):R243-R249.

67. Engel J Jr, International League Against Epilepsy. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(6):796-803.

68. National Institute of Neurological Disorders and Stroke. The Epilepsies and Seizures: Hope Through Research. Available at https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Epilepsies-and-Seizures-Hope-Through. Last accessed October 25, 2021.

69. Fuller G, Manford M. Neurology: An Illustrated Colour Text. 3rd ed. Edinburgh: Churchill Livingstone Publisher; 2010.

70. Bryce TN. Spinal Cord Injury. New York, NY: Demos Medical; 2010.

71. MedlinePlus. Interferon Beta-1a Subcutaneous Injection. Available at https://medlineplus.gov/druginfo/meds/a604005.html. Last accessed October 25, 2021.

72. Blumenfeld H. Neuroanatomy Through Clinical Cases. 2nd ed. Sunderland, MA: Sinouer Associates; 2010.

73. Caplan LR. Uncommon Causes of Stroke. 3rd ed. Cambridge: Cambridge University Press; 2018.

74. Greer DM. Acute Ischemic Stroke. Hoboken, NJ: Wiley-Liss; 2007.

75. Hennerici MG. Case Studies in Stroke: Common and Uncommon Presentations. Cambridge: Cambridge University Press; 2007.

76. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67-e492.

77. National Heart, Lung, and Blood Institute. 2012 NHLBI Incidence and Prevalence Chart Book on Cardiovascular and Lung Diseases. Available at https://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf. Last accessed October 25, 2021.

78. Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78(2):188-191.

79. Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc. 2005;80(3):420-433.

80. Shah QA, Ezzeddine MA, Qureshi AI. Acute hypertension in intracerebral hemorrhage: pathophysiology and treatment. J Neurol Sci. 2007;261(1-2):74-79.

81. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, American Heart Association Stroke Council and Council on Cardiovascular Nursing. Stroke. 2010;41(9):2108-2129.

82. Counsell C, Boonyakarnkul S, Dennis M, et al. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project: prognosis. Cerebrovasc Dis. 1995;5:26-34.

83. Flaherty ML, Haverbusch M, Sekar PK, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66(8):1182-1186.

84. Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral hemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(6):660-667.

85. Sutherland GR, Auer RN. Primary intracerebral hemorrhage. J Clin Neuroscience. 2006;13:511-517.

86. Qureshi AI, Tuhrim S, Broderick JP, Batjer H, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.

87. Ritter MA, Droste DW, Hegedüs, et al. Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology. 2005;64(7):1233-1237.

88. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.

89. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387-396.

90. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124(pt 2):249-278.

91. Niewwkamp DJ, de Wilde A, Wermer MJ, Algra A, Rinkel GJ. Long-term outcome after aneurysmal subarachnoid hemorrhage—risks of vascular events, death from cancer and all-cause death. J Neurol. 2014;261(2):309-315.

92. Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59(11):1750-1758.

93. MedlinePlus. Cerebral Arteriovenous Malformation. Available at https://medlineplus.gov/ency/article/000779.htm. Last accessed October 25, 2021.

94. Flaherty ML, Haverbusch M, Kissela B, et al. Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome.J Stroke Cerebrovasc Dis. 2005;14(6):267-271.

95. Konczalla J, Kashefiolasl S, Brawanski N, Senft C, Seifert V, Platz J. Increasing numbers of nonaneurysmal subarachnoid hemorrhage in the last 15 years: antithrombotic medication as reason and prognostic factor? J Neurosurg. 2016;124(6):1731-1731.

96. Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke. Lancet Neurol. 2006;5(9):755-768.

97. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.

98. Jauch EC, Al Kasab S. Ischemic Stroke. Available at https://emedicine.medscape.com/article/1916852-overview. Last accessed October 25, 2021.

99. Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-3035.

100. Birschel P, Ellul J, Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc Dis. 2004;17(2-3):242-252.

101. Hayashi K, Kitagawa N, Takahata H, et al. Endovascular treatment for cervical carotid artery stenosis presenting with progressing stroke: three case reports. Surg Neurol. 2002;58(2):148-154.

102. Du Mesnil de Rochemont R, Sitzer M, Neumann-Haefelin T, Harmjanz A, Berkefeld J. Endovascular recanalization of acute atherothrombotic carotid artery occlusion holds up progressive stroke. Neuroradiology. 2004;46(7):583-586.

103. Rerkasem K, Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke. 2009;40:e564-e572.

104. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467.

105. Winstein CJ, Stein J, Arena R, et al. AHA/ASA guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98-e169.

106. Langhorne P, Stott DJ, Robertson L, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31(6):1223-1229.

107. Giles MF, Rothwell PM. Risk of stroke early after transient ischemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6(12):1063-1072.

108. Albers GW, Caplan LR, Easton JD, et al. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347(21):1713-1716.

109. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009;40(6):2276-2293.

110. Gladstone DJ. Toward an emergency response to transient ischemic attacks. Postgrad Med J. 2005;117(1):9-14.

111. Fisher CM. Transient ischemic attacks. N Engl J Med. 2002;347(21):1642-1643.

112. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901-2906.

113. Levy DE. How transient are transient ischemic attacks? Neurology. 1988;38(5):647-677.

114. Henry GL, Johnston SC, Pinkowish MD. Acute neurologic symptoms—TIA, migraine, or something else? Patient Care. 2004;38(3):50-56.

115. Nanda A, Singh NN. Transient Ischemic Attack. Available at https://emedicine.medscape.com/article/1910519-overview. Last accessed October 25, 2021.

116. Ko DY, Sahai-Srivastava S. Generalized Tonic-Clonic Seizures. Available at https://emedicine.medscape.com/article/1184608-overview. Last accessed October 25, 2021.

117. Epilepsy Foundation. Types of Seizures. Available at https://www.epilepsy.com/learn/types-seizures. Last accessed October 25, 2021.

118. Johns Hopkins Medicine. Generalized Seizures. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/epilepsy/generalized-seizures. Last accessed October 25, 2021.

119. Centers for Disease Control and Prevention. Epilepsy. Available at https://www.cdc.gov/epilepsy/index.html. Last accessed October 25, 2021.

120. Ko DY. Epilepsy and Seizures. Available at https://emedicine.medscape.com/article/1184846-overview. Last accessed October 25, 2021.

121. Adamolekun B. Seizure Disorders. Available at https://www.merckmanuals.com/professional/neurologic-disorders/seizure-disorders/seizure-disorders. Last accessed October 25, 2021.

122. St. Louis EK, Rosenfeld WE, Bramley T. Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol. 2009;7:77-82.

123. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Headache in Adults: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008.

124. World Health Organization. Headache Disorders. Available at http://www.who.int/en/news-room/fact-sheets/detail/headache-disorders. Last accessed October 25, 2021.

125. International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.

126. MedlinePlus. Tension Headache. Available at https://medlineplus.gov/ency/article/000797.htm. Last accessed October 25, 2021.

127. National Institute on Aging. Basics of Alzheimer's Disease and Dementia. Available at https://www.nia.nih.gov/health/alzheimers/basics. Last accessed October 25, 2021.

128. Alzheimer's Association. 2021 Alzheimer's Disease Facts and Figures. Available at https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf. Last accessed October 25, 2021.

129. National Institute on Aging. What Causes Alzheimer's Disease? Available at https://www.nia.nih.gov/health/what-causes-alzheimers-disease. Last accessed October 25, 2021.

130. Alzheimer's Association. Stages of Alzheimer's. Available at https://www.alz.org/alzheimers-dementia/stages. Last accessed October 25, 2021.

131. Kuller LH, Lopez OL, Becker JT, et al. Risk of dementia and death in the long-term follow-up of the Pittsburgh Cardiovascular Health Study–Cognition Study. Alzheimers Dement. 2016;12(2):170-183.

132. Solfrizzi V, Frisardi V, Seripa D, et al. Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res. 2011;8(5):520-542.

133. Winslow BT, Onysko MK, Stob CM, Hazlewood KA. Treatment of Alzheimer disease. Am Fam Physician. 2011;83(12):1403-1412.

134. Seltzer B. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. J Int Med Res. 2006;34(4):339-347.

135. National Institute on Aging. How is Alzheimer's Disease Treated? Available at https://www.nia.nih.gov/health/how-alzheimers-disease-treated. Last accessed October 25, 2021.

136. Alzheimer's Association. Medications for Memory. Available at https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory. Last accessed October 25, 2021.

137. Beier MT. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Pharmacotherapy. 2007;27(3):399-411.

138. DeMaagd G, Philip A. Parkinson's disease and its management. Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. PT. 2015;40(8):504-532.

139. Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am Fam Physician. 2013;87(4):267-273.

140. Williams DR, Litvan I. Parkinsonian syndromes. Continuum (Minneap Minn). 2013;19(5):11890-11212.

141. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318(1):121-134.

142. Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol. 2015;14(1):57-64.

143. Braak H, Bohl JR, Muller CM, et al. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord. 2006;21(12):2042-2051.

144. Williams DR, Lees AJ. How do patients with parkinsonism present? A clinicopathological study. Intern Med J. 2009;39(1):7-12.

145. Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med. 2012;2(6):a008870.

146. Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson's disease. Subcell Biochem. 2012;65:389-455.

147. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30(12):1591-1599.

148. Jenner P. Treatment of the later stages of Parkinson's disease: pharmacological approaches now and in the future. Transl Neurodegener. 2015;4:3.

149. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502-1517.

150. Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9(5):520-532.

151. Frohman TC, O'Donoghue DL, Northrop D (eds). Multiple Sclerosis for the Physician Assistant: A Practical Primer. New York, NY: National Multiple Sclerosis Society; 2011.

152. National Multiple Sclerosis Society. Symptoms and Diagnosis. Available at https://www.nationalmssociety.org/Symptoms-Diagnosis. Last accessed October 25, 2021.

153. Hersh CM, Fox RJ. Disease Management: Multiple Sclerosis. Available at https://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/neurology/multiple_sclerosis/Default.htm. Last accessed October 25, 2021.

154. Rae-Grant A, Day GS, Marrie RA, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(17):777-788.

155. MedlinePlus. Interferon Beta-1a Intramuscular Injection. Available at https://medlineplus.gov/druginfo/meds/a693040.html. Last accessed October 25, 2021.

156. Saitoh Y, Takahashi Y. Riluzole for the treatment of amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2020;10(6):343-355.

157. National Institute on Neurological Disorders and Stroke. Myasthenia Gravis Fact Sheet. Available at https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Myasthenia-Gravis-Fact-Sheet. Last accessed October 25, 2021.

158. Dhillon S. Eculizumab: a review in generalized myasthenia gravis. Drugs. 2018;78(3):367-376.

159. Genetic and Rare Diseases Information Center. Herpes Simplex Encephalitis. Available at https://rarediseases.info.nih.gov/diseases/6649/herpes-simplex-encephalitis. Last accessed October 25, 2021.

160. Icahn School of Medicine at Mount Sinai. Viral Encephalitis. Available at https://www.mountsinai.org/health-library/report/viral-encephalitis. Last accessed October 25, 2021.

161. LexiComp Online. Available at https://online.lexi.com. Last accessed October 25, 2021.

Evidence-Based Practice Recommendations Citations

1. Brown MD, Burton JH, Nazarian DJ, Promes SB, American College of Emergency Physicians. Clinical policy: use of intravenous tissue plasminogen activator for the management of acute ischemic stroke in the emergency department. Ann Emerg Med. 2015;66(3):322-333. Available at https://www.acep.org/globalassets/new-pdfs/clinical-policies/tpa-for-stroke_new.pdf. Last accessed November 18, 2021.

2. Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705-1713. Available at https://www.aan.com/Guidelines/home/GetGuidelineContent/688. Last accessed November 18, 2021.

3. Douglas AC, Wippold FJ II, Broderick DF, et al. ACR Appropriateness Criteria: Headache. Reston, VA: American College of Radiology; 2019. Available at https://acsearch.acr.org/docs/69482/Narrative. Last accessed November 18, 2021.

4. Fletcher K. Nursing Standard of Practice Protocol: Recognition and Management of Dementia. Abstract available from Guideline Central at https://www.guidelinecentral.com/summaries/recognition-and-management-of-dementia-in-evidence-based-geriatric-nursing-protocols-for-best-practice. Last accessed November 18, 2021.

5. Preissner K. Occupational Therapy Practice Guidelines for Adults with Neurodegenerative Diseases. Bethesda, MD: American Occupational Therapy Association, Inc.; 2014. Abstract available from Guideline Central at https://www.guidelinecentral.com/summaries/occupational-therapy-practice-guidelines-for-adults-with-neurodegenerative-diseases. Last accessed November 18, 2021.

6. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. Available at https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30470-2/fulltext. Last accessed November 18, 2021.

7. Theodore N, Aarabi B, Dhall SS, et al. Transportation of patients with acute traumatic cervical spine injuries. In: Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;72(Suppl 2):35-39. Available at https://academic.oup.com/neurosurgery/article/72/suppl_3/35/2557442. Last accessed November 18, 2021.


Copyright © 2021 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.